The burden of infant group B streptococcal infections in Ontario: Analysis of administrative data to estimate the potential benefits of new vaccines
Group B streptococcus (GBS) is a leading bacterial cause of neonatal sepsis and meningitis in many countries as well as an important cause of disease in pregnant women. Currently, serotype-specific conjugate vaccines are being developed. We conducted an epidemiological analysis of health administrat...
Saved in:
Main Authors: | James Hartley (Author), Ye Li (Author), Liz Kunkel (Author), Natasha S. Crowcroft (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
by: Delphine Laho, et al.
Published: (2021) -
Burden of infant group B Streptococcus disease and impact of maternal screening and antibiotic prophylaxis in Ontario, Canada: a population-based cohort studyResearch in context
by: Romina Fakhraei, et al.
Published: (2024) -
Group B streptococcal infective endocarditis
by: Mahmoud Abdelghany, et al.
Published: (2014) -
Epidemiology of group B streptococcal infection in pregnant women and diseased infants in mainland China
by: Jing Huang, et al.
Published: (2019) -
An approach to estimating the environmental burden of cancer from known and probable carcinogens: application to Ontario, Canada
by: Susan Lavinia Greco, et al.
Published: (2020)